Age 0 3 0 3 B-age
> 4 5 4 5 O
21 5 7 5 7 B-lower_bound
years 8 13 8 13 I-lower_bound
to 14 16 14 16 O
< 17 18 17 18 O
70 18 20 18 20 B-upper_bound
years 21 26 21 26 I-upper_bound

Chronically 0 11 27 38 O
active 12 18 39 45 O
inflammatory 19 31 46 58 O
or 32 34 59 61 O
neoplastic 35 45 62 72 B-chronic_disease
disease 46 53 73 80 I-chronic_disease
in 54 56 81 83 O
the 57 60 84 87 O
three 61 66 88 93 O
years 67 72 94 99 O
prior 73 78 100 105 O
to 79 81 106 108 O
enrollment 82 92 109 119 O

Diabetes 0 8 120 128 B-chronic_disease
management 9 19 129 139 O
by 20 22 140 142 O
metformin 23 32 143 152 O
or 33 35 153 155 O
lifestyle 36 45 156 165 O
intervention 46 58 166 178 O

Diagnosed 0 9 179 188 O
with 10 14 189 193 O
T2DM 15 19 194 198 B-chronic_disease
within 20 26 199 205 O
2 27 28 206 207 B-upper_bound
years 29 34 208 213 I-upper_bound
with 35 39 214 218 O
an 40 42 219 221 O
HbA1c<7 43 50 222 229 B-clinical_variable
% 50 51 229 230 I-upper_bound

currently 0 9 231 240 O
trying 10 16 241 247 O
to 17 19 248 250 O
become 20 26 251 257 B-pregnancy
pregnant 27 35 258 266 I-pregnancy

have 0 4 267 271 O
a 5 6 272 273 O
history 7 14 274 281 O
of 15 17 282 284 O
heart 18 23 285 290 B-chronic_disease
disease 24 31 291 298 I-chronic_disease
, 31 32 298 299 O
kidney 33 39 300 306 B-chronic_disease
disease 40 47 307 314 I-chronic_disease
, 47 48 314 315 O
or 49 51 316 318 O
retinopathy 52 63 319 330 B-chronic_disease
( 64 65 331 332 O
to 65 67 332 334 O
rule 68 72 335 339 O
- 72 73 339 340 O
out 73 76 340 343 O
those 77 82 344 349 O
with 83 87 350 354 O
long 88 92 355 359 O
- 92 93 359 360 O
standing 93 101 360 368 O
, 101 102 368 369 O
undiagnosed 103 114 370 381 O
T2D 115 118 382 385 O
) 118 119 385 386 O

have 0 4 387 391 O
had 5 8 392 395 O
or 9 11 396 398 O
are 12 15 399 402 O
planning 16 24 403 411 O
to 25 27 412 414 O
have 28 32 415 419 O
bariatric 33 42 420 429 B-treatment
surgery 43 50 430 437 I-treatment
during 51 57 438 444 O
the 58 61 445 448 O
study 62 67 449 454 O

those 0 5 455 460 O
who 6 9 461 464 O
use 10 13 465 468 O
acetaminophen 14 27 469 482 B-treatment
and 28 31 483 486 O
are 32 35 487 490 O
unwilling 36 45 491 500 O
or 46 48 501 503 O
unable 49 55 504 510 O
to 56 58 511 513 O
discontinue 59 70 514 525 O
its 71 74 526 529 O
use 75 78 530 533 O
during 79 85 534 540 O
the 86 89 541 544 O
study 90 95 545 550 O
( 96 97 551 552 O
acetaminophen 97 110 552 565 O
affects 111 118 566 573 O
CGM 119 122 574 577 O
accuracy)39 123 134 578 589 O

those 0 5 590 595 O
with 6 10 596 600 O
an 11 13 601 603 O
active 14 20 604 610 B-chronic_disease
infection 21 30 611 620 I-chronic_disease
requiring 31 40 621 630 O
antibiotics 41 52 631 642 B-treatment
in 53 55 643 645 O
the 56 59 646 649 O
last 60 64 650 654 B-upper_bound
3 65 66 655 656 I-upper_bound
months 67 73 657 663 I-upper_bound
or 74 76 664 666 O
who 77 80 667 670 O
develop 81 88 671 678 O
an 89 91 679 681 O
active 92 98 682 688 O
infection 99 108 689 698 O
requiring 109 118 699 708 O
antibiotics 119 130 709 720 O
during 131 137 721 727 O
the 138 141 728 731 O
study 142 147 732 737 O

who 0 3 738 741 O
become 4 10 742 748 O
pregnant 11 19 749 757 B-pregnancy
during 20 26 758 764 O
the 27 30 765 768 O
study 31 36 769 774 O

